Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
AN2 Therapeutics Inc.
Director
Vistagen Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. June 19, 202489.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | AN2 Therapeutics Inc. | Open-market purchase | +2,098 | $5.53 | $11,602 |
| May 28, 2025 | AN2 Therapeutics Inc. | Open-market purchase | +8,610 | $1.18 | $10,160 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.